More than 152,000 new cases of NMSC are diagnosed every year – more than breast, prostate and lung […]

Phase I/II study results demonstrate proof-of-concept and proof-of-biology of tofersen

The two agencies have agreed to share research and knowledge

Clinigen has bagged a US orphan drug designation (ODD) for its investigational Amyotrophic Lateral Sclerosis (ALS) treatment aldesleukin.

GSK’s national TV push for Nucala gives another meaning to ‘new normal’ beth.bulik Sun, 07/12/2020 – 19:00

Updated Date: Mon, 06 Jul 2020 00:00:00 EDT

Updated Date: Mon, 06 Jul 2020 00:00:00 EDT

Updated Date: Mon, 06 Jul 2020 00:00:00 EDT

Updated Date: Mon, 06 Jul 2020 00:00:00 EDT

Updated Date: Mon, 06 Jul 2020 00:00:00 EDT